Keyword Search Results for "fibrinolytic"

Hillis, L. D., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., High dose intravenous streptokinase for acute myocardial infarction: preliminary results of a multicenter trial Journal of the American College of Cardiology. 1985;6(5):957-62. Abstract

Williams, D. O., Borer, J., Braunwald, E., Chesebro, J. H., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Knatterud, G., Ludbrook, P., et al., Intravenous recombinant tissue-type plasminogen activator in patients with acute myocardial infarction: a report from the NHLBI thrombolysis in myocardial infarction trial Circulation. 1986;73(2):338-46. Abstract

Braunwald, E., Knatterud, G. L., Passamani, E. R., Robertson, T. L. Announcement of protocol change in thrombolysis in myocardial infarction trial Journal of the American College of Cardiology. 1987;9(2):467.

Braunwald, E., Knatterud, G. L., Passamani, E., Robertson, T. L., Solomon, R. Update from the Thrombolysis in Myocardial Infarction Trial Journal of the American College of Cardiology. 1987;10(4):970.

Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Hillis, D., Ludbrook, P., et al., Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation. 1987;76(1):142-54. Abstract

Gore, J. M., Roberts, R., Ball, S. P., Montero, A., Goldberg, R. J., Dalen, J. E. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction American Journal of Cardiology. 1987;59(15):1234-8. Abstract

Holmes, D. R., Jr., Bove, A. A., Nishimura, R. A., Gehring, D. G., Chesebro, J. H., Owen, R. M., Smith, H. C. Comparison of monoplane and biplane assessment of regional left ventricular wall motion after thrombolytic therapy for acute myocardial infarction American Journal of Cardiology. 1987;59(8):793-7. Abstract

Mueller, H. S., Rao, A. K., Forman, S. A. Thrombolysis in myocardial infarction (TIMI): comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator Journal of the American College of Cardiology. 1987;10(3):479-90. Abstract

Owen, J., Friedman, K. D., Grossman, B. A., Wilkins, C., Berke, A. D., Powers, E. R. Quantitation of fragment X formation during thrombolytic therapy with streptokinase and tissue plasminogen activator Journal of clinical investigation. 1987;79(6):1642-7. Abstract

Passamani, E., Hodges, M., Herman, M., Grose, R., Chaitman, B., Rogers, W., Forman, S., Terrin, M., Knatterud, G., Robertson, T., et al., The Thrombolysis in Myocardial Infarction (TIMI) phase II pilot study: tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty Journal of the American College of Cardiology. 1987;10(5 Suppl 2):51B-64B. Abstract

Sheehan, F. H., Braunwald, E., Canner, P., Dodge, H. T., Gore, J., Van Natta, P., Passamani, E. R., Williams, D. O., Zaret, B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial Circulation. 1987;75(4):817-29. Abstract

Williams, D. O., Ruocco, N. A., Forman, S. Coronary angioplasty after recombinant tissue-type plasminogen activator in acute myocardial infarction: a report from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1987;10(5 Suppl B):45B-50B. Abstract

Immediate vs delayed catheterization and angioplasty following thrombolytic therapy for acute myocardial infarction. TIMI II A results. The TIMI Research Group JAMA. 1988;260:2849-58. Abstract

Dalen, J. E., Gore, J. M., Braunwald, E., Borer, J., Goldberg, R. J., Passamani, E. R., Forman, S., Knatterud, G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial American Journal of Cardiology. 1988;62(4):179-85. Abstract

Held, A. C., Gore, J. M., Paraskos, J., Pape, L. A., Ball, S. P., Corrao, J. M., Alpert, J. S. Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction American Journal of Cardiology. 1988;62(4):310-1.

Rao, A. K., Pratt, C., Berke, A., Jaffe, A., Ockene, I., Schreiber, T. L., Bell, W. R., Knatterud, G., Robertson, T. L., Terrin, M. L. Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase Journal of the American College of Cardiology. 1988;11(1):11-Jan. Abstract

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. The TIMI Study Group. N Engl J Med. 1989;320:618-27. Abstract

Chaitman, B. R., Thompson, B., Wittry, M. D., Stump, D., Hamilton, W. P., Hillis, L. D., Dwyer, J. G., Solomon, R. E., Knatterud, G. L. The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly: results from thrombolysis in myocardial infarction Phase I, open label studies and the Thrombolysis in Myocardial Infarction Phase II pilot study. The TIMI Investigators Journal of the American College of Cardiology. 1989;14(5):1159-65. Abstract

Gibbons, R. J., Verani, M. S., Behrenbeck, T., Pellikka, P. A., O'Connor, M. K., Mahmarian, J. J., Chesebro, J. H., Wackers, F. J. Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction Circulation. 1989;80(5):1277-86. Abstract

Rogers, W. J., Bourge, R. C., Papapietro, S. E., Wackers, F. J., Zaret, B. L., Forman, S., Dodge, H. T., Robertson, T. L., Passamani, E. R., Braunwald, E., et al., Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction phase II (TIMI II) pilot study American journal of cardiology. 1989;63(9):503-12. Abstract

Sharkey, S. W., Bruneete, D. D., Ruiz, E., Hession, W. T., Wysham, D. G., Goldenberg, I. F., Hodges, M. An analysis of time delays preceding thrombolysis for acute myocardial infarction JAMA. 1989;262(22):3171-4. Abstract

Wackers, F. J., Gibbons, R. J., Verani, M. S., Kayden, D. S., Pellikka, P. A., Behrenbeck, T., Mahmarian, J. J., Zaret, B. L. Serial quantitative planar technetium-99m isonitrile imaging in acute myocardial infarction: efficacy for noninvasive assessment of thrombolytic therapy Journal of the American College of Cardiology. 1989;14(4):861-73. Abstract

Wackers, F. J., Terrin, M. L., Kayden, D. S., Knatterud, G., Forman, S., Braunwald, E., Zaret, B. L. Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial Journal of the American College of Cardiology. 1989;13(5):998-1005. Abstract

Chaitman, B. R., Thompson, B. W., Kern, M. J., Vandormael, M. G., Cohen, M. B., Ruocco, N. A., Solomon, R. E., Braunwald, E. Tissue plasminogen activator followed by percutaneous transluminal coronary angioplasty: one-year TIMI phase II pilot results. TIMI Investigators American heart journal. 1990;119(2 Pt 1):213-23. Abstract

Feit, F., Mueller, H. S., Braunwald, E., Ross, R., Hodges, M., Herman, M. V., Knatterud, G. L. Thrombolysis in Myocardial Infarction (TIMI) phase II trial: outcome comparison of a "conservative strategy" in community versus tertiary hospitals. The TIMI Research Group Journal of the American College of Cardiology. 1990;16(7):1529-34. Abstract

Gertz, S. D., Kalan, J. M., Kragel, A. H., Roberts, W. C., Braunwald, E. Cardiac morphologic findings in patients with acute myocardial infarction treated with recombinant tissue plasminogen activator American Journal of Cardiology. 1990;65(15):953-61. Abstract

Gertz, S. D., Kragel, A. H., Kalan, J. M., Braunwald, E., Roberts, W. C. Comparison of coronary and myocardial morphologic findings in patients with and without thrombolytic therapy during fatal first acute myocardial infarction. The TIMI Investigators American Journal of Cardiology. 1990;66(12):904-9. Abstract

Hillis, L. D., Forman, S., Braunwald, E. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. The Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators Journal of the American College of Cardiology. 1990;16(2):313-5. Abstract

Kayden, D. S., Wackers, F. J., Zaret, B. L. Silent left ventricular dysfunction during routine activity after thrombolytic therapy for acute myocardial infarction Journal of the American College of Cardiology. 1990;15(7):1500-7. Abstract

Lawler, C. M., Bovill, E. G., Stump, D. C., Collen, D. J., Mann, K. G., Tracy, R. P. Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction Blood. 1990;76(7):1341-8. Abstract

Rogers, W. J., Baim, D. S., Gore, J. M., Brown, B. G., Roberts, R., Williams, D. O., Chesebro, J. H., Babb, J. D., Sheehan, F. H., Wackers, F. J., et al., Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial Circulation. 1990;81(5):1457-76. Abstract

Bovill, E. G., Terrin, M. L., Stump, D. C., Berke, A. D., Frederick, M., Collen, D., Feit, F., Gore, J. M., Hillis, L. D., Lambrew, C. T., et al., Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial Annals of internal medicine. 1991;115(4):256-65. Abstract

Gore, J. M., Sloan, M., Price, T. R., Randall, A. M., Bovill, E., Collen, D., Forman, S., Knatterud, G. L., Sopko, G., Terrin, M. L. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial Circulation. 1991;83(2):448-59. Abstract

Roberts R, Rogers WJ, Mueller HS, Lambrew CT, Diver DJ, Smith HC, Willerson JT, Knatterud GL, Forman S, Passamani E, et al. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. Circulation. 1991;83:422-37. Abstract

Zaret, Barry L., Wackers, Frans J., Terrin, Michael, Ross, Richard, Knatterud, Genell, Braunwald, Eugene Does left ventricular ejection fraction following thrombolytic therapy have the same prognostic impact described in the prethrombolytic era? Results of the TIMI II trail Journal of the American College of Cardiology. 1991;17(2, Supplement 1):A214.

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Frederick, M. M., Jacobs, A. K., Faxon, D. P. Incidence and prognostic implications of heart block complicating inferior myocardial infarction treated with thrombolytic therapy: results from TIMI II Journal of the American College of Cardiology. 1992;20(3):533-40. Abstract

Braunwald, E., Cannon, C. P., McCabe, C. H. An approach to evaluating thrombolytic therapy in acute myocardial infarction. The 'unsatisfactory outcome' end point Circulation. 1992;86(2):683-7.

Braunwald, E., Knatterud, G., Passamani, E. The rt-PA versus streptokinase. Controversy--II Journal of the American College of Cardiology. 1992;19(5):1116-9.

Kleiman, N. S., Terrin, M., Mueller, H., Chaitman, B., Roberts, R., Knatterud, G. L., Solomon, R., McMahon, R. P., Braunwald, E. Mechanisms of early death despite thrombolytic therapy: experience from the Thrombolysis in Myocardial Infarction Phase II (TIMI II) study Journal of the American College of Cardiology. 1992;19(6):1129-35. Abstract

Mueller, H. S., Cohen, L. S., Braunwald, E., Forman, S., Feit, F., Ross, A., Schweiger, M., Cabin, H., Davison, R., Miller, D., et al., Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II Circulation. 1992;85(4):1254-64. Abstract

Ruocco, N. A., Jr., Bergelson, B. A., Jacobs, A. K., Frederick, M. M., Faxon, D. P., Ryan, T. J. Invasive versus conservative strategy after thrombolytic therapy for acute myocardial infarction in patients with antecedent angina. A report from Thrombolysis in Myocardial Infarction Phase II (TIMI II) Journal of the American College of Cardiology. 1992;20(7):1445-51. Abstract

Tofler, G. H., Muller, J. E., Stone, P. H., Forman, S., Solomon, R. E., Knatterud, G. L., Braunwald, E. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group Journal of the American College of Cardiology. 1992;20(5):1049-55. Abstract

Williams, D. O., Braunwald, E., Knatterud, G., Babb, J., Bresnahan, J., Greenberg, M. A., Raizner, A., Wasserman, A., Robertson, T., Ross, R. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial Circulation. 1992;85(2):533-42. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Ross, R., Weiss, M., Slater, J., Morrison, J., Bourge, R. C., Passamani, E., Knatterud, G., et al., Assessment of global and regional left ventricular performance at rest and during exercise after thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) II Study American journal of cardiology. 1992;69(1):9-Jan. Abstract

Early effects of tissue-type plasminogen activator added to conventional therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest. Results of the Thrombolysis in Myocardial Ischemia (TIMI IIIA) Trial. Circulation. 1993;87:38-52. Abstract

Berger, P. B., Ruocco, N. A., Jr., Ryan, T. J., Jacobs, A. K., Zaret, B. L., Wackers, F. J., Frederick, M. M., Faxon, D. P. Frequency and significance of right ventricular dysfunction during inferior wall left ventricular myocardial infarction treated with thrombolytic therapy (results from the thrombolysis in myocardial infarction [TIMI] II trial). The TIMI Research Group American journal of cardiology. 1993;71(13):1148-52. Abstract

Berger, P. B., Ruocco, N. A., Ryan, T. J., Frederick, M. M., Podrid, P. J. Incidence and significance of ventricular tachycardia and fibrillation in the absence of hypotension or heart failure in acute myocardial infarction treated with recombinant tissue-type plasminogen activator: results from the Thrombolysis in Myocardial Infarction (TIMI) Phase II trial Journal of the American College of Cardiology. 1993;22(7):1773-9. Abstract

Chaitman, B. R., McMahon, R. P., Terrin, M., Younis, L. T., Shaw, L. J., Weiner, D. A., Frederick, M. M., Knatterud, G. L., Sopko, G., Braunwald, E. Impact of treatment strategy on predischarge exercise test in the Thrombolysis in Myocardial Infarction (TIMI) II Trial American journal of cardiology. 1993;71(2):131-8. Abstract

Lehmann, K. G., Francis, C. K., Sheehan, F. H., Dodge, H. T. Effect of thrombolysis on acute mitral regurgitation during evolving myocardial infarction. Experience from the Thrombolysis in Myocardial Infarction (TIMI) Trial Journal of the American College of Cardiology. 1993;22(3):714-9. Abstract

Simoons, M. L., Maggioni, A. P., Knatterud, G., Leimberger, J. D., de Jaegere, P., van Domburg, R., Boersma, E., Franzosi, M. G., Califf, R., Schroder, R., et al., Individual risk assessment for intracranial haemorrhage during thrombolytic therapy Lancet. 1993;342(8886-8887):1523-8. Abstract

Taylor, H. A., Chaitman, B. R., Rogers, W. J., Kern, M. J., Terrin, M. L., Aguirre, F. V., Sopko, G., McMahon, R., Ross, R. N., Bovill, E. C. Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial Circulation. 1993;88(4 Pt 1):1484-94. Abstract

Terrin, M. L., Williams, D. O., Kleiman, N. S., Willerson, J., Mueller, H. S., Desvigne-Nickens, P., Forman, S. A., Knatterud, G. L., Braunwald, E. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II clinical trial Journal of the American College of Cardiology. 1993;22(7):1763-72. Abstract

Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Circulation. 1994;89:1545-56. Abstract

Becker, R. C., Terrin, M., Ross, R., Knatterud, G. L., Desvigne-Nickens, P., Gore, J. M., Braunwald, E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators Annals of internal medicine. 1994;120(8):638-45. Abstract

Cannon, C. P., Antman, E. M., Walls, R., Braunwald, E. Time as an Adjunctive Agent to Thrombolytic Therapy J Thromb Thrombolysis. 1994;1(1):27-34. Abstract

Cannon, C. P., McCabe, C. H., Diver, D. J., Herson, S., Greene, R. M., Shah, P. K., Sequeira, R. F., Leya, F., Kirshenbaum, J. M., Magorien, R. D., et al., Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial J Am Coll Cardiol. 1994;24:1602-10. Abstract

Cox, D. A., Rogers, W. J., Aguirre, F. V., Forman, S., Solomon, R., Zaret, B. L. Effect on outcome of the presence or absence of chest pain at initiation of recombinant tissue plasminogen activator therapy in acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators American journal of cardiology. 1994;73(11):729-36. Abstract

Diver, D. J., Bier, J. D., Ferreira, P. E., Sharaf, B. L., McCabe, C., Thompson, B., Chaitman, B., Williams, D. O., Braunwald, E. Clinical and arteriographic characterization of patients with unstable angina without critical coronary arterial narrowing (from the TIMI-IIIA Trial) American journal of cardiology. 1994;74(6):531-7. Abstract

Schweiger, M. J., McMahon, R. P., Terrin, M. L., Ruocco, N. A., Porway, M. N., Wiseman, A. H., Knatterud, G. L., Braunwald, E. Comparison of patients with < 60% to > or = 60% diameter narrowing of the myocardial infarct-related artery after thrombolysis. The TIMI Investigators American journal of cardiology. 1994;74(2):105-10. Abstract

Anderson, H. V., Cannon, C. P., Stone, P. H., Williams, D. O., McCabe, C. H., Knatterud, G. L., Thompson, B., Willerson, J. T., Braunwald, E. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction Journal of the American College of Cardiology. 1995;26(7):1643-50. Abstract

Boisjolie, C. R., Sharkey, S. W., Cannon, C. P., Brunette, D., Haugland, J. M., Thatcher, J. L., Henry, T. D. Impact of a thrombolysis research trial on time to treatment for acute myocardial infarction in the emergency department American journal of cardiology. 1995;76(5):396-8. Abstract

Cannon, C. P., Thompson, B., McCabe, C. H., Mueller, H. S., Kirshenbaum, J. M., Herson, S., Nasmith, J. B., Chaitman, B. R., Braunwald, E. Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trials American journal of cardiology. 1995;75(15):977-81. Abstract

Gersh, B. J., Chesebro, J. H., Braunwald, E., Lambrew, C., Passamani, E., Solomon, R. E., Ross, A. M., Ross, R., Terrin, M. L., Knatterud, G. L. Coronary artery bypass graft surgery after thrombolytic therapy in the Thrombolysis in Myocardial Infarction Trial, Phase II (TIMI II) Journal of the American College of Cardiology. 1995;25(2):395-402. Abstract

Gibson, C. M., Cannon, C. P., Piana, R. N., Breall, J. A., Sharaf, B., Flatley, M., Alexander, B., Diver, D. J., McCabe, C. H., Flaker, G. C., et al., Angiographic predictors of reocclusion after thrombolysis: results from the Thrombolysis in Myocardial Infarction (TIMI) 4 trial Journal of the American College of Cardiology. 1995;25(3):582-9. Abstract

Hall, C., Cannon, C. P., Forman, S., Braunwald, E. Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Thrombolysis in Myocardial Infarction (TIMI) II Investigators Journal of the American College of Cardiology. 1995;26(6):1452-6. Abstract

Mueller, Hiltrud S., Forman, Sandra A., Menegus, Mark A., Cohen, Lawrence S., Knatterud, Genell L., Braunwald, Eugene Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial Journal of the American College of Cardiology. 1995;26(4):900-907.

Sloan, M. A., Price, T. R., Petito, C. K., Randall, A. M., Solomon, R. E., Terrin, M. L., Gore, J., Collen, D., Kleiman, N., Feit, F., et al., Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience Neurology. 1995;45(4):649-58. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Davis, V., Braunwald, E., Shah, P. K. How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 trial) American journal of cardiology. 1995;75(4):232-6. Abstract

Zahger, D., Cercek, B., Cannon, C. P., Jordan, M., Shah, P. K. Thrombolytic Therapy for Acute Myocardial Infarction in Patients with Prior Coronary Bypass Surgery: Results from the Thrombolysis in Myocardial Infarction (TIMI) 4 Trial Journal of thrombosis and thrombolysis. 1995;2(1):45-50. Abstract

Zaret, B. L., Wackers, F. J., Terrin, M. L., Forman, S. A., Williams, D. O., Knatterud, G. L., Braunwald, E. Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis in Myocardial Infarction (TIMI) phase II study. The TIMI Study Group Journal of the American College of Cardiology. 1995;26(1):73-9. Abstract

Becker, R. C., Cannon, C. P., Bovill, E. G., Tracy, R. P., Thompson, B., Knatterud, G. L., Randall, A., Braunwald, B. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial) American journal of cardiology. 1996;78(2):142-7. Abstract

Becker, R. C., Cannon, C. P., Tracy, R. P., Thompson, B., Bovill, E. G., Desvigne-Nickens, P., Randall, A. M., Knatternud, G., Braunwald, E. Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators American heart journal. 1996;131(3):421-33. Abstract

Birnbaum, Y., Kloner, R. A., Sclarovsky, S., Cannon, C. P., McCabe, C. H., Davis, V. G., Zaret, B. L., Wackers, F. J., Braunwald, E. Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial) American journal of cardiology. 1996;78(4):396-403. Abstract

Gibson, C. M., Cannon, C. P., Daley, W. L., Dodge, J. T., Jr., Alexander, B., Jr., Marble, S. J., McCabe, C. H., Raymond, L., Fortin, T., Poole, W. K., Braunwald, E. TIMI frame count: a quantitative method of assessing coronary artery flow Circulation. 1996;93(5):879-88. Abstract

Scharfstein, J. S., Abendschein, D. R., Eisenberg, P. R., George, D., Cannon, C. P., Becker, R. C., Sobel, B., Cupples, L. A., Braunwald, E., Loscalzo, J. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. TIMI-5 Investigators. Thrombolysis in Myocardial Infarction American journal of cardiology. 1996;78(5):503-10. Abstract

Cannon CP, McCabe CH, Gibson CM, Ghali M, Sequeira RF, McKendall GR, Breed J, Modi NB, Fox NL, Tracy RP, Love TW, Braunwald E. TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial. Circulation. 1997;95:351-6. Abstract

Cannon, C. P., McCabe, C. H., Stone, P. H., Rogers, W. J., Schactman, M., Thompson, B. W., Pearce, D. J., Diver, D. J., Kells, C., Feldman, T., Williams, M., Gibson, R. S., Kronenberg, M. W., Ganz, L. I., Anderson, H. V., Braunwald, E. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III Registry ECG Ancillary Study. Thrombolysis in Myocardial Ischemia Journal of the American College of Cardiology. 1997;30(1):133-40. Abstract

Cannon, C. P., Sharis, P. J., Schweiger, M. J., McCabe, C. H., Diver, D. J., Shah, P. K., Sequeira, R. F., Greene, R. M., Perritt, R. L., Poole, W. K., Braunwald, E. Prospective validation of a composite end point in thrombolytic trials of acute myocardial infarction (TIMI 4 and 5). Thrombosis In Myocardial Infarction American journal of cardiology. 1997;80(6):696-9. Abstract

Gibson, C. M., Cannon, C. P., Greene, R. M., Sequeira, R. F., Margorien, R. D., Leya, F., Diver, D. J., Baim, D. S., Braunwald, E. Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial American journal of cardiology. 1997;80(1):21-6. Abstract

Gibson, C. M., Marble, S. J., Rizzo, M. J., Moynihan, J., McLean, C., Ryan, K., Sparano, A., Piana, R. N., McCabe, C., Cannon, C. P. Relation between injections before 90-minute angiography and coronary patency: results of the thrombolysis in myocardial infarction 4 trial American heart journal. 1997;134(3):351-4. Abstract

Hochman, J. S., McCabe, C. H., Stone, P. H., Becker, R. C., Cannon, C. P., DeFeo-Fraulini, T., Thompson, B., Steingart, R., Knatterud, G., Braunwald, E. Outcome and profile of women and men presenting with acute coronary syndromes: a report from TIMI IIIB. TIMI Investigators. Thrombolysis in Myocardial Infarction Journal of the American College of Cardiology. 1997;30(1):141-8. Abstract

Jain, D., Thompson, B., Wackers, F. J., Zaret, B. L. Relevance of increased lung thallium uptake on stress imaging in patients with unstable angina and non-Q wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI)-IIIB Study Journal of the American College of Cardiology. 1997;30(2):421-9. Abstract

Sloan, M. A., Price, T. R., Terrin, M. L., Forman, S., Gore, J. M., Chaitman, B. R., Hodges, M., Mueller, H., Rogers, W. J., Knatterud, G. L., Braunwald, E. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience Stroke. 1997;28(6):1107-14. Abstract

Tanasijevic, M. J., Cannon, C. P., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Antman, E. M., Braunwald, E. Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10A American heart journal. 1997;134(4):622-30. Abstract

Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, Grollier G, Giugliano RP, Frey M, Mueller HS, Steingart RM, Weaver WD, Van de Werf F, Braunwald E. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Circulation. 1998;98:2805-14. Abstract

Kloner, R. A., Przyklenk, K., Shook, T., Cannon, C. P. Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial Journal of thrombosis and thrombolysis. 1998;6(2):89-92. Abstract

Modi, N. B., Eppler, S., Breed, J., Cannon, C. P., Braunwald, E., Love, T. W. Pharmacokinetics of a slower clearing tissue plasminogen activator variant, TNK-tPA, in patients with acute myocardial infarction Thrombosis and haemostasis. 1998;79(1):134-9. Abstract

Sagarin, M. J., Cannon, C. P., Cermignani, M. S., Scirica, B. M., Walls, R. M. Delay in thrombolysis administration: causes of extended door-to-drug times and the asymptote effect J Emerg Med. 1998;16(4):557-65. Abstract

Cannon, C. P., Johnson, E. B., Cermignani, M., Scirica, B. M., Sagarin, M. J., Walls, R. M. Emergency department thrombolysis critical pathway reduces door-to-drug times in acute myocardial infarction Clin Cardiol. 1999;22(1):17-20. Abstract

Gibson CM, Ryan KA, Kelley M, Rizzo MJ, Mesley R, Murphy S, Swanson J, Marble SJ, Dodge JT, Giugliano RP, Cannon CP, Antman EM. Methodologic drift in the assessment of TIMI grade 3 flow and its implications with respect to the reporting of angiographic trial results. Am Heart J. 1999;137:1179-84. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Adgey, A. A., Schweiger, M. J., Sequeira, R. F., Grollier, G., Fox, N. L., Berioli, S., Weaver, W. D., Van de Werf, F., Braunwald, E. Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators Am J Cardiol. 1999;84(9):976-80. Abstract

Gibson, C. M., Murphy, S. A., Rizzo, M. J., Ryan, K. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Van de Werf, F., Braunwald, E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Circulation. 1999;99(15):1945-50. Abstract

Gibson, C. M., Murphy, S., Menown, I. B., Sequeira, R. F., Greene, R., Van de Werf, F., Schweiger, M. J., Ghali, M., Frey, M. J., Ryan, K. A., Marble, S. J., Giugliano, R. P., Antman, E. M., Cannon, C. P., Braunwald, E. Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction J Am Coll Cardiol. 1999;34(5):1403-12. Abstract

Tanasijevic, M. J., Cannon, C. P., Antman, E. M., Wybenga, D. R., Fischer, G. A., Grudzien, C., Gibson, C. M., Winkelman, J. W., Braunwald, E. Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarction: results from the Thrombolysis in Myocardial Infarction study (TIMI) 10B J Am Coll Cardiol. 1999;34(3):739-47. Abstract

Van de Werf, F., Cannon, C. P., Luyten, A., Houbracken, K., McCabe, C. H., Berioli, S., Bluhmki, E., Sarelin, H., Wang-Clow, F., Fox, N. L., Braunwald, E. Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators Am Heart J. 1999;137(5):786-91. Abstract

Cannon, C. P., Sayah, A. J., Walls, R. M. ER TIMI-19: testing the reality of prehospital thrombolysis J Emerg Med. 2000;19(3 Suppl):21S-25S.

Coulter, S. A., Cannon, C. P., Ault, K. A., Antman, E. M., Van de Werf, F., Adgey, A. A., Gibson, C. M., Giugliano, R. P., Mascelli, M. A., Scherer, J., Barnathan, E. S., Braunwald, E., Kleiman, N. S. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14 Circulation. 2000;101(23):2690-5. Abstract

Gibson, C. M., Anshelevich, M., Murphy, S., Luu, L., Hynes, C., Kliris, J., Kermgard, S., Otten, M. H., Antman, E. M., Cannon, C. P., Braunwald, E. Impact of injections during diagnostic coronary arteriography on coronary patency in the setting of acute myocardial infarction from the TIMI trials. Thrombolysis In Myocardial Infarction Am J Cardiol. 2000;86(12):1378-9, A5. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Ryan, K. A., Mesley, R., Marble, S. J., McCabe, C. H., Van De Werf, F., Braunwald, E. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs Circulation. 2000;101(2):125-30. Abstract

Llevadot, J., Giugliano, R. P., McCabe, C. H., Cannon, C. P., Antman, E. M., Murphy, S., Gibson, C. M. Degree of residual stenosis in the culprit coronary artery after thrombolytic administration (Thrombolysis In Myocardial Infarction [TIMI] trials) Am J Cardiol. 2000;85(12):1409-13. Abstract

Modi, N. B., Fox, N. L., Clow, F. W., Tanswell, P., Cannon, C. P., Van de Werf, F., Braunwald, E. Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction J Clin Pharmacol. 2000;40(5):508-15. Abstract

The InTIMI-II Investigators. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction. Eur Heart J. 2000;21:2005-13. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., McCabe, C. H., Murphy, S. A., Van de Werf, F., Gibson, C. M., Braunwald, E. ST-segment resolution and infarct-related artery patency and flow after thrombolytic therapy. Thrombolysis in Myocardial Infarction (TIMI) 14 investigators Am J Cardiol. 2000;85(3):299-304. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Charlesworth, A., Schroder, R., Braunwald, E. Very early risk stratification after thrombolytic therapy with a bedside myoglobin assay and the 12-lead electrocardiogram Am Heart J. 2000;140(3):373-8. Abstract

de Lemos, J. A., Antman, E. M., Giugliano, R. P., Morrow, D. A., McCabe, C. H., Cutler, S. S., Charlesworth, A., Schroder, R., Braunwald, E. Comparison of a 60- versus 90-minute determination of ST-segment resolution after thrombolytic therapy for acute myocardial infarction. In TIME-II Investigators. Intravenous nPA for Treatment of Infarcting Myocardium Early-II Am J Cardiol. 2000;86(11):1235-7, A5. Abstract

de Lemos, J. A., Antman, E. M., Morrow, D. A., Llevadot, J., Giugliano, R. P., Coulter, S. A., Schuhwerk, K. C., Arslanian, S., McCabe, C. H., Gibson, C. M., Rifai, N. Heart-type fatty acid binding protein as a marker of reperfusion after thrombolytic therapy Clin Chim Acta. 2000;298(2-Jan):85-97. Abstract

Gibson, C. M., Kirtane, A. J., Murphy, S. A., Marble, S. J., de Lemos, J. A., Antman, E. M., Braunwald, E. Impact of contrast agent type (ionic versus nonionic) used for coronary angiography on angiographic, electrocardiographic, and clinical outcomes following thrombolytic administration in acute myocardial infarction Catheter Cardiovasc Interv. 2001;53(1):11-Jun. Abstract

Gibson, C. M., Marble, S. J. Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA) Clin Cardiol. 2001;24(9):577-84. Abstract

Gibson, C. M., Murphy, S. A., Marble, S. J., McCabe, C. H., Antman, E. M., Cannon, C. P., Braunwald, E. Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials? TIMI Study Group Am J Cardiol. 2001;87(4):450-3, A6. Abstract

Gibson, C. M., de Lemos, J. A., Murphy, S. A., Marble, S. J., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy Circulation. 2001;103(21):2550-4. Abstract

Giugliano, R. P., Llevadot, J., Wilcox, R. G., Gurfinkel, E. P., McCabe, C. H., Charlesworth, A., Thompson, S. L., Antman, E. M., Braunwald, E. Geographic variation in patient and hospital characteristics, management, and clinical outcomes in ST-elevation myocardial infarction treated with fibrinolysis. Results from InTIME-II Eur Heart J. 2001;22(18):1702-15. Abstract

Giugliano, R. P., McCabe, C. H., Antman, E. M., Cannon, C. P., Van de Werf, F., Wilcox, R. G., Braunwald, E. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage Am Heart J. 2001;141(5):742-50. Abstract

Llevadot, J., Giugliano, R. P., Antman, E. M., Wilcox, R. G., Gurfinkel, E. P., Henry, T., McCabe, C. H., Charlesworth, A., Thompson, S., Nicolau, J. C., Tebbe, U., Sadowski, Z., Braunwald, E. Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction Eur Heart J. 2001;22(22):2104-15. Abstract

Schweiger, M. J., Cannon, C. P., Murphy, S. A., Gibson, C. M., Cook, J. R., Giugliano, R. P., Changezi, H. U., Antman, E. M., Braunwald, E. Early coronary intervention following pharmacologic therapy for acute myocardial infarction (the combined TIMI 10B-TIMI 14 experience) Am J Cardiol. 2001;88(8):831-6. Abstract

Srinivas, V. S., Cannon, C. P., Gibson, C. M., Antman, E. M., Greenberg, M. A., Tanasijevic, M. J., Murphy, S., de Lemos, J. A., Sokol, S., Braunwald, E., Mueller, H. S. Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy Am Heart J. 2001;142(1):29-36. Abstract

Wang-Clow, F., Fox, N. L., Cannon, C. P., Gibson, C. M., Berioli, S., Bluhmki, E., Danays, T., Braunwald, E., Van De Werf, F., Stump, D. C. Determination of a weight-adjusted dose of TNK-tissue plasminogen activator Am Heart J. 2001;141(1):33-40. Abstract

de Lemos, J. A., Morrow, D. A., Gibson, C. M., Murphy, S. A., Rifai, N., Tanasijevic, M., Giugliano, R. P., Schuhwerk, K. C., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Early noninvasive detection of failed epicardial reperfusion after fibrinolytic therapy Am J Cardiol. 2001;88(4):353-8. Abstract

Antman, E. M., Cooper, H. A., Gibson, C. M., de Lemos, J. A., McCabe, C. H., Giugliano, R. P., Coussement, P., Murphy, S., Scherer, J., Anderson, K., Van de Werf, F., Braunwald, E. Determinants of improvement in epicardial flow and myocardial perfusion for ST elevation myocardial infarction; insights from TIMI 14 and InTIME-II Eur Heart J. 2002;23(12):928-33. Abstract

Cooper, H. A., de Lemos, J. A., Morrow, D. A., Sabatine, M. S., Murphy, S. A., McCabe, C. H., Gibson, C. M., Antman, E. M., Braunwald, E. Minimal ST-segment deviation: a simple, noninvasive method for identifying patients with a patent infarction-related artery after fibrinolytic administration Am Heart J. 2002;144(5):790-5. Abstract

Gibson, C. M., Cannon, C. P., Murphy, S. A., Marble, S. J., Barron, H. V., Braunwald, E. Relationship of the TIMI myocardial perfusion grades, flow grades, frame count, and percutaneous coronary intervention to long-term outcomes after thrombolytic administration in acute myocardial infarction Circulation. 2002;105(16):1909-13. Abstract

Kloner, R. A., Poole, K., Shook, T., Przyklenk, K., Perritt, K., Cannon, C. P. Comparison of acute myocardial infarct size in patients > or =65 years versus < 65 years in the prethrombolytic period versus the thrombolytic period American journal of cardiology. 2002;89(11):1291-3.

Morrow DA, Antman EM, Sayah A, Schuhwerk KC, Giugliano RP, deLemos JA, Waller M, Cohen SA, Rosenberg DG, Cutler SS, McCabe CH, Walls RM, Braunwald E. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction: results of The Early Retavase-Thrombolysis in Myocardial Infarction (ER-TIMI) 19 trial. J Am Coll Cardiol. 2002;40:71-7.

Murphy, S. A., Chen, C., Cannon, C. P., Antman, E. M., Gibson, C. M. Impact of gender on angiographic and clinical outcomes after fibrinolytic therapy in acute myocardial infarction Am J Cardiol. 2002;90(7):766-70.

Murphy, S. A., Gibson, C. M., Van de Werf, F., McCabe, C. H., Cannon, C. P. Comparison of errors in estimating weight and in dosing of single-bolus tenecteplase with tissue plasminogen activator (TIMI 10B and ASSENT I) Am J Cardiol. 2002;90(1):51-4.

Shields, D. C., Fitzgerald, A. P., O'Neill, P. A., Muckian, C., Kenny, D., Moran, B., Cannon, C. P., Byrne, C. E., Fitzgerald, D. J. The contribution of genetic factors to thrombotic and bleeding outcomes in coronary patients randomised to IIb/IIIa antagonists Pharmacogenomics J. 2002;2(3):182-90. Abstract

Gibson, C. M., Karha, J., Murphy, S. A., James, D., Morrow, D. A., Cannon, C. P., Giugliano, R. P., Antman, E. M., Braunwald, E. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the Thrombolysis in Myocardial Infarction trials J Am Coll Cardiol. 2003;42(1):16-Jul. Abstract

Gibson, C. M., Pinto, D. S., Murphy, S. A., Morrow, D. A., Hobbach, H. P., Wiviott, S. D., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Timi Study Group Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality J Am Coll Cardiol. 2003;42(9):1535-43. Abstract

Gibson, C. M., Bigelow, B., James, D., Tepper, M. R., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M. Association of lesion complexity following fibrinolytic administration with mortality in ST-elevation myocardial infarction Am J Cardiol. 2004;94(1):108-11. Abstract

Gibson, C. M., Murphy, S. A., Kirtane, A. J., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of duration of symptoms at presentation with angiographic and clinical outcomes after fibrinolytic therapy in patients with ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(5):980-7. Abstract

Giugliano, R. P., Sabatine, M. S., Gibson, C. M., Roe, M. T., Harrington, R. A., Murphy, S. A., Morrow, D. A., Antman, E. M., Braunwald, E. Combined assessment of thrombolysis in myocardial infarction flow grade, myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and myocardial reperfusion Am J Cardiol. 2004;93(11):1362-7, A5-6. Abstract

Karmpaliotis, D., Turakhia, M. P., Kirtane, A. J., Murphy, S. A., Kosmidou, I., Morrow, D. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E., Gibson, C. M. Sequential risk stratification using TIMI risk score and TIMI flow grade among patients treated with fibrinolytic therapy for ST-segment elevation acute myocardial infarction Am J Cardiol. 2004;94(9):1113-7. Abstract

Kirtane, A. J., Bui, A., Murphy, S. A., Karmpaliotis, D., Kosmidou, I., Boundy, K., Rahman, A., Pinto, D. S., Aroesty, J. M., Giugliano, R. P., Cannon, C. P., Antman, E. M., Gibson, C. M. Association of epicardial and tissue-level reperfusion with left ventricular end-diastolic pressures in ST-elevation myocardial infarction J Thromb Thrombolysis. 2004;17(3):177-84. Abstract

Wiviott, S. D., Morrow, D. A., Frederick, P. D., Giugliano, R. P., Gibson, C. M., McCabe, C. H., Cannon, C. P., Antman, E. M., Braunwald, E. Performance of the thrombolysis in myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality in ST-segment elevation myocardial infarction J Am Coll Cardiol. 2004;44(4):783-9. Abstract

Gibson, C. M., Kirtane, A. J., Boundy, K., Ly, H., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Braunwald, E. Association of a negative residual stenosis following rescue/adjunctive percutaneous coronary intervention with impaired myocardial perfusion and adverse outcomes among ST-segment elevation myocardial infarction patients J Am Coll Cardiol. 2005;45(3):357-62. Abstract

Kashani, A., Gibson, C. M., Murphy, S. A., Sabatine, M. S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation acute myocardial infarction Am J Cardiol. 2005;95(2):228-33. Abstract

Kirtane, A. J., Weisbord, A., Karmpaliotis, D., Murphy, S. A., Giugliano, R. P., Cannon, C. P., Antman, E. M., Ohman, E. M., Roe, M. T., Braunwald, E., Gibson, C. M. Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction Am J Cardiol. 2005;95(2):224-7. Abstract

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Claeys, M. J., Cools, F., Hill, K. A., Skene, A. M., McCabe, C. H., Braunwald, E. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med. 2005;352(12):1179-89.

Sabatine, M. S., Cannon, C. P., Gibson, C. M., Lopez-Sendon, J. L., Montalescot, G., Theroux, P., Lewis, B. S., Murphy, S. A., McCabe, C. H., Braunwald, E. Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-elevation myocardial infarction treated with fibrinolytics: the PCI-CLARITY study JAMA. 2005;294(10):1224-32.

Sabatine, M. S., McCabe, C. H., Gibson, C. M., Cannon, C. P. Design and rationale of Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 trial Am Heart J. 2005;149(2):227-33.

Sabatine, M. S., Morrow, D. A., Montalescot, G., Dellborg, M., Leiva-Pons, J. L., Keltai, M., Murphy, S. A., McCabe, C. H., Gibson, C. M., Cannon, C. P., Antman, E. M., Braunwald, E. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial Circulation. 2005;112(25):3846-54.

Ahmed, S., Antman, E. M., Murphy, S. A., Giugliano, R. P., Cannon, C. P., White, H., Morrow, D. A., Braunwald, E. Poor outcomes after fibrinolytic therapy for ST-segment elevation myocardial infarction: impact of age (a meta-analysis of a decade of trials) J Thromb Thrombolysis. 2006;21(2):119-29. Abstract

Gibson, C. M., Zorkun, C., Molhoek, P., Zmudka, K., Greenberg, M., Mueller, H., Wesdorp, J., Louwerenburg, H., Niederman, A., Westenburg, J., Bikkina, M., Batty, J., de Winter, J., Murphy, S. A., McCabe, C. H. Dose escalation trial of the efficacy, safety, and pharmacokinetics of a novel fibrinolytic agent, BB-10153, in patients with ST elevation MI: results of the TIMI 31 trial J Thromb Thrombolysis. 2006;22(1):13-21.

Kirtane, A. J., Vafai, J. J., Murphy, S. A., Aroesty, J. M., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographically evident thrombus following fibrinolytic therapy is associated with impaired myocardial perfusion in STEMI: a CLARITY-TIMI 28 substudy Eur Heart J. 2006;27(17):2040-5.

Matheny, M. E., Morrow, D. A., Ohno-Machado, L., Cannon, C. P., Resnic, F. S. Validating an automated outcomes surveillance application using data from a terminated randomized, controlled trial (OPUS [TIMI-16]) AMIA Annu Symp Proc. 2007;NA(NA):1043. Abstract

Mega, J. L., Morrow, D. A., Ostor, E., Dorobantu, M., Qin, J., Antman, E. M., Braunwald, E. Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation myocardial infarction Circulation. 2007;115(22):2822-2828. Abstract

Gibson, C. M., Pride, Y. B., Buros, J. L., Kunadian, V., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Braunwald, E. Relation of hyperemic epicardial flow to outcomes among patients with ST-segment elevation myocardial infarction receiving fibrinolytic therapy Am J Cardiol. 2008;101(9):1232-8.

Gibson, C. M., Pride, Y. B., Buros, J. L., Lord, E., Shui, A., Murphy, S. A., Pinto, D. S., Zimetbaum, P. J., Sabatine, M. S., Cannon, C. P., Josephson, M. E. Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction J Am Coll Cardiol. 2008;51(5):546-51.

O'Donoghue, M., Morrow, D. A., Cannon, C. P., Guo, W., Murphy, S. A., Gibson, C. M., Sabatine, M. S. Association between baseline neutrophil count, clopidogrel therapy, and clinical and angiographic outcomes in patients with ST-elevation myocardial infarction receiving fibrinolytic therapy Eur Heart J. 2008;29(8):984-91.

Pinto, D. S., Kirtane, A. J., Pride, Y. B., Murphy, S. A., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Association of blood glucose with angiographic and clinical outcomes among patients with ST-segment elevation myocardial infarction (from the CLARITY-TIMI-28 study) Am J Cardiol. 2008;101(3):303-7.

Pride, Y. B., Buros, J. L., Lord, E., Southard, M. C., Harrigan, C. J., Ciaglo, L. N., Sabatine, M. S., Cannon, C. P., Gibson, C. M. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days J Thromb Thrombolysis. 2008;26(2):106-12. Abstract

Sabatine, M. S., Hamdalla, H. N., Mehta, S. R., Fox, K. A., Topol, E. J., Steinhubl, S. R., Cannon, C. P. Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use Am Heart J. 2008;155(5):910-7.

Sabatine, M. S., Morrow, D. A., Higgins, L. J., MacGillivray, C., Guo, W., Bode, C., Rifai, N., Cannon, C. P., Gerszten, R. E., Lee, R. T. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction Circulation. 2008;117(15):1936-44.

Braunwald, E. [TIMI group study of thrombolysis in myocardial infarction] Ter Arkh. 2009;81(5):78-84. Abstract

Giraldez, R. R., Wiviott, S. D., Nicolau, J. C., Mohanavelu, S., Morrow, D. A., Antman, E. M., Giugliano, R. P. Streptokinase and enoxaparin as an alternative to fibrin-specific lytic-based regimens: an ExTRACT-TIMI 25 analysis Drugs. 2009;69(11):1433-43. Abstract

Pride, Y. B., Appelbaum, E., Lord, E. E., Sloan, S., Cannon, C. P., Sabatine, M. S., Gibson, C. M. Relation between myocardial infarct size and ventricular tachyarrhythmia among patients with preserved left ventricular ejection fraction following fibrinolytic therapy for ST-segment elevation myocardial infarction Am J Cardiol. 2009;104(4):475-9.

Harkness, J. R., Sabatine, M. S., Braunwald, E., Morrow, D. A., Sloan, S., Wiviott, S. D., Giugliano, R. P., Antman, E. M., Cannon, C. P., Scirica, B. M. Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation myocardial infarction Am Heart J. 2010;159(1):55-62. Abstract

Wilson, Sean R., Wiviott, Stephen D., Antman, Elliott M., Giugliano, Robert P., Murphy, Sabina A., Sloan, Sarah, Braunwald, Eugene, Morrow, David A. APPLICATION OF THE TIMI RISK SCORE, A SIMPLE BEDSIDE TOOL, FOR TIMING OF DISCHARGE AFTER FIBRINOLYSIS OR PRIMARY ANGIOPLASTY FOR ST-ELEVATION MI IN THE EXTRACT-TIMI 25 AND TRITON-TIMI 38 TRIALS Journal of the American College of Cardiology. 2010;55(10, Supplement):A125.E1173.

Abtahian, F., Olenchock, B., Ou, F. S., Kontos, M. C., Saucedo, J. F., Scirica, B. M., Desai, N., Peterson, E., Roe, M., Cannon, C. P., Wiviott, S. D. Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry) Am J Cardiol. 2011;107(10):1441-6. Abstract

Kunadian, V., Pride, Y. B., Buros, J. L., Ciaglo, L. N., Morrow, D. A., Gibson, C. M. Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: a PROTECT TIMI-30 analysis J Thromb Thrombolysis. 2011;32(4):448-52. Abstract

Mogabgab, O., Giugliano, R. P., Sabatine, M. S., Cannon, C. P., Mohanavelu, S., Wiviott, S. D., Antman, E. M., Braunwald, E. Circadian Variation in Patient Characteristics and Outcomes in ST-Segment Elevation Myocardial Infarction Chronobiology International. 2012;29(10):1390-1396. Abstract

Udell, Jacob A, O'Donoghue, Michelle L, Braunwald, Eugene, Scirica, Benjamin M, Wiviott, Stephen D, Bansilal, Sameer, Hoffman, Elaine B, Sabatine, Marc S, Cannon, Christopher P Abstract 15090: Evaluation of Right Bundle Branch Block for Risk Prediction and Guiding Revascularization Strategy in Patients with Non-ST-Elevation Acute Coronary Syndrome in the TACTICS-TIMI 18 Trial Circulation. 2012;126(21 Supplement):A15090.

Schwamm, L. H., Ali, S. F., Reeves, M. J., Smith, E. E., Saver, J. L., Messe, S., Bhatt, D. L., Grau-Sepulveda, M. V., Peterson, E. D., Fonarow, G. C. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at get with the guidelines-stroke hospitals Circ Cardiovasc Qual Outcomes. 2013;6(5):543-9. Abstract

Fonarow, G. C., Zhao, X., Smith, E. E., Saver, J. L., Reeves, M. J., Bhatt, D. L., Xian, Y., Hernandez, A. F., Peterson, E. D., Schwamm, L. H. Door-to-needle times for tissue plasminogen activator administration and clinical outcomes in acute ischemic stroke before and after a quality improvement initiative JAMA. 2014;311(16):1632-40. Abstract

Waks, J. W., Sabatine, M. S., Cannon, C. P., Morrow, D. A., Gibson, C. M., Wiviott, S. D., Giugliano, R. P., Sloan, S., Scirica, B. M. Clinical Implications and Correlates of Q Waves in Patients With ST-Elevation Myocardial Infarction Treated With Fibrinolysis: Observations from the CLARITY-TIMI 28 Trial Clin Cardiol. 2014;37(3):160-6. Abstract

Xian, Y., Smith, E. E., Zhao, X., Peterson, E. D., Olson, D. M., Hernandez, A. F., Bhatt, D. L., Saver, J. L., Schwamm, L. H., Fonarow, G. C. Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke Stroke. 2014;45(5):1387-95. Abstract